Keating Financial Advisory Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Keating Financial Advisory Services's RPRX Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Royalty Pharma (RPRX) stake by 23% in Q2 2026, buying an estimated $2.92K and bringing the position to 300 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.
Keating Financial Advisory Services first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Keating Financial Advisory Services held 300 shares of Royalty Pharma worth $16.8K as of Q2 2026.
- Keating Financial Advisory Services bought 56 Royalty Pharma shares in Q2 2026, an estimated $2.92K.
- Royalty Pharma made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1049 holding.
- Keating Financial Advisory Services first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
- 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.